Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.47 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 2/20 | 0.42 |
| ▸ | PKM | P14618 | 2/20 | 0.42 |
| ▸ | RAB9A | P51151 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.41 |
| ▸ | AURKA | O14965 | 1/20 | 0.41 |
| ▸ | RPS6KB1 | P23443 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2751452 | 0.96 | MAPT (0.43) | MAPTPOLBL3MBTL1HCAR3KDM4E | |
| SCHEMBL2751335 | 0.77 | KDM5B (0.49) | MAPTPOLBL3MBTL1KDM4EALDH1A1 | |
| SCHEMBL18280144 | 0.74 | HPGD (0.47) | ALDH1A1HPGDPKMCYP3A4 | |
| SCHEMBL30969102 | 0.74 | MAPT (0.47) | MAPTPOLBKDM4EALDH1A1HPGD | |
| SCHEMBL2471450 | 0.73 | HCAR3 (0.43) | MAPTPOLBHCAR3KDM4EHPGD | |
| SCHEMBL28573810 | 0.73 | KDM4E (0.45) | MAPTL3MBTL1KDM4EALDH1A1GAA | |
| SCHEMBL28323432 | 0.73 | HPGD (0.63) | MAPTPOLBL3MBTL1KDM4EALDH1A1 | |
| Hydrochloric Acid SCHEMBL2472732 | 0.72 | KDM4C (0.43) | MAPTPOLBHCAR3KDM4EHPGD | |
| SCHEMBL3675628 | 0.72 | POLB (0.46) | MAPTPOLBL3MBTL1KDM4EALDH1A1 | |
| SCHEMBL2278307 | 0.71 | KMT2A (0.48) | MAPTKDM4EALDH1A1HPGDSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2370177-B1 | NOVEL COSMETIC COMPOSITIONS HAVING HAIR GROWTH INHIBITING EFFECT | HENKEL AG & CO KGAA (DE) | 2017-11-15 | — | — | EP | claimed |
| EP-1949887-A2 | Cosmetic formulas for skin smoothing and tautening | Henkel AG & Co. KGaA (DE) | 2008-07-30 | — | — | EP | claimed |
| EP-1938789-A1 | Improvement of the skin friendliness of hyperemizing agents | Henkel AG & Co. KGaA (DE) | 2008-07-02 | — | — | EP | claimed |
| EP-2370177-B1 | NOVEL COSMETIC COMPOSITIONS HAVING HAIR GROWTH INHIBITING EFFECT | HENKEL AG & CO KGAA (DE) | 2017-11-15 | — | — | EP | disclosed |
| EP-2370177-A2 | NOVEL COSMETIC COMPOSITIONS HAVING HAIR GROWTH INHIBITING EFFECT | Henkel AG & Co. KGaA (DE) | 2011-10-05 | — | — | EP | disclosed |
| EP-2238964-A2 | Stabilised cosmetic compounds | Henkel AG & Co. KGaA (DE) | 2010-10-13 | — | — | EP | disclosed |
| US-20100227896-A1 | USE OF VITAMIN PP COMPOUNDS | ASTELLAS DEUTSCHLAND GMBH (DE) | 2010-09-09 | — | — | US | disclosed |
| WO-2010063673-A2 | NOVEL COSMETIC COMPOSITIONS HAVING HAIR GROWTH INHIBITING EFFECT | HENKEL AG & CO. KGAA (DE) | 2010-06-10 | — | — | WO | disclosed |
| EP-1949887-A2 | Cosmetic formulas for skin smoothing and tautening | Henkel AG & Co. KGaA (DE) | 2008-07-30 | — | — | EP | disclosed |
| EP-1938789-A1 | Improvement of the skin friendliness of hyperemizing agents | Henkel AG & Co. KGaA (DE) | 2008-07-02 | — | — | EP | disclosed |
| EP-1079832-B1 | USE OF VITAMIN PP COMPOUNDS | KLINGE CO CHEM PHARM FAB (DE) | 2005-11-30 | — | — | EP | disclosed |
| EP-1079832-A1 | USE OF VITAMIN PP COMPOUNDS | Klinge Pharma GmbH (DE) | 2001-03-07 | — | — | EP | disclosed |
| WO-1999053920-A1 | USE OF VITAMIN PP COMPOUNDS | KLINGE PHARMA GMBH (DE) | 1999-10-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100227896-A1 | USE OF VITAMIN PP COMPOUNDS | PNPO, NAMPT, NAPRT | MAPT 2497/4885POLB 1119/4885L3MBTL1 4790/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.